ES2149979T3 - Composicion estabilizada para la administracion oral de peptidos. - Google Patents

Composicion estabilizada para la administracion oral de peptidos.

Info

Publication number
ES2149979T3
ES2149979T3 ES95914605T ES95914605T ES2149979T3 ES 2149979 T3 ES2149979 T3 ES 2149979T3 ES 95914605 T ES95914605 T ES 95914605T ES 95914605 T ES95914605 T ES 95914605T ES 2149979 T3 ES2149979 T3 ES 2149979T3
Authority
ES
Spain
Prior art keywords
pct
oral administration
spheres
sec
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95914605T
Other languages
English (en)
Inventor
Anne Fjellestad-Paulsen
Christina Ahlm-Soderberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring BV
Original Assignee
Ferring BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring BV filed Critical Ferring BV
Application granted granted Critical
Publication of ES2149979T3 publication Critical patent/ES2149979T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH

Abstract

COMPUESTO FARMACEUTICO SOLIDO PARA LA ADMINISTRACION ORAL DE PEPTIDOS DE MEDIANO Y PEQUEÑO TAMAÑO, ESPECIALMENTE VASOPRESINA, OXITOCINA Y SUS ANALOGOS, QUE CONSTA DE DICHO PEPTIDO, UNA CUBIERTA ENTERICA Y UN VEHICULO ACEPTABLE FARMACEUTICAMENTE QUE CONTIENE UN AGENTE AMORTIGUADOR A UN PH DE 2 A 6, SIENDO PREFERIBLE UN PH DE 5 APROXIMADAMENTE. EL METODO DE FABRICACION DE DOSIS SIMPLES DE DICHO PEPTIDO CONSISTE EN MEZCLAR LOS INGREDIENTES Y CONFORMAR LA MEZCLA EN ESFERAS INFERIORES A 2MM, LAS CUALES SE CUBREN CON UNA CUBIERTA ENTERICA FACILMENTE SOLUBLE EN UN JUGO GASTRICO DE PH 5.0 O MAYOR PERO NO EN UN PH SUSTANCIALMENTE INFERIOR, Y DICHAS ESFERAS CUBIERTAS SE CARGAN EN CAPSULAS O SE INTRODUCEN EN COMPRIMIDOS DEGRADABLES EN EL ESTOMAGO. TAMBIEN SE MUESTRA UN METODO PARA LA ADMINISTRACION ORAL A UN PACIENTE DE UNA DOSIS SIMPLE.
ES95914605T 1994-03-18 1995-03-09 Composicion estabilizada para la administracion oral de peptidos. Expired - Lifetime ES2149979T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9400918A SE9400918L (sv) 1994-03-18 1994-03-18 Stabiliserad komposition för oral administrering av peptider

Publications (1)

Publication Number Publication Date
ES2149979T3 true ES2149979T3 (es) 2000-11-16

Family

ID=20393330

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95914605T Expired - Lifetime ES2149979T3 (es) 1994-03-18 1995-03-09 Composicion estabilizada para la administracion oral de peptidos.

Country Status (24)

Country Link
US (1) US5763405A (es)
EP (1) EP0752877B1 (es)
JP (1) JP3249970B2 (es)
CN (1) CN1143911A (es)
AT (1) ATE194290T1 (es)
AU (1) AU679852B2 (es)
BR (1) BR9506989A (es)
CA (1) CA2183862C (es)
CZ (1) CZ285810B6 (es)
DE (1) DE69517801T2 (es)
DK (1) DK0752877T3 (es)
ES (1) ES2149979T3 (es)
FI (1) FI114688B (es)
GR (1) GR3034440T3 (es)
HU (1) HU214826B (es)
NO (1) NO316055B1 (es)
NZ (1) NZ283462A (es)
PL (1) PL181866B1 (es)
PT (1) PT752877E (es)
RO (1) RO115123B1 (es)
RU (1) RU2140790C1 (es)
SE (1) SE9400918L (es)
SK (1) SK281640B6 (es)
WO (1) WO1995025534A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922680A (en) * 1996-10-23 1999-07-13 Ferring, B.V. Stabilized composition for oral administration of peptides
SE9604341D0 (sv) 1996-11-26 1996-11-26 Ferring Bv Hepta-peptide oxytocin analogue
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US8088734B2 (en) 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
US7094545B2 (en) 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
DE60300414T2 (de) * 2003-04-30 2006-05-11 Ferring B.V. Feste Dosierungsform mit Desmopressin
DE60301351T2 (de) 2003-07-25 2006-01-19 Ferring B.V. Pharmazeutische Desmopressin-Zubereitung als feste Darreichungsform und Methode zu ihrer Herstellung
DE60305043T2 (de) * 2003-11-13 2006-11-30 Ferring B.V. Blisterverpackung und feste Dosierungsform enthaltend Desmopressin
US7018653B2 (en) 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
US8399410B2 (en) 2007-08-06 2013-03-19 Allergan, Inc. Methods and devices for desmopressin drug delivery
ES2319054B1 (es) 2007-08-06 2010-02-12 Gp Pharm S.A. Composicion farmaceutica oral de desmopresina.
ES2677548T3 (es) * 2008-05-21 2018-08-03 Ferring B.V. Desmopresina bucodispersable para aumentar el periodo inicial de sueño ininterrumpido por nicturia
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
EP2161030A1 (en) * 2008-09-09 2010-03-10 Rijksuniversiteit te Groningen Oxytocin formulations and uses thereof
RU2015144851A (ru) 2009-06-18 2019-01-10 Серенити Фармасьютикалз, Элэлси Безопасное применение десмопрессина
DK2598553T3 (da) * 2010-07-26 2016-08-01 Univ Geneve Sammensætninger omfattende polymerer fremstillede af 2-hydroxyalkylsyrer
CN102146122A (zh) * 2010-11-12 2011-08-10 深圳市健元医药科技有限公司 一种具有宫缩作用药物的生产工艺
SE536091C2 (sv) * 2011-04-14 2013-04-30 Pep Tonic Medical Ab Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter
ES2821822T3 (es) * 2014-10-01 2021-04-27 Oxytone Bioscience B V Unidad de dosificación farmacéutica sólida desintegrante por vía oral que contiene una sustancia de control de partos
WO2019180561A1 (en) 2018-03-20 2019-09-26 Mankind Pharma Ltd. Stable pharmaceutical composition of vasopressin
AU2019345166B2 (en) 2018-09-20 2021-09-02 Levo Therapeutics, Inc. Stable intranasal formulations of carbetocin
TW202034899A (zh) 2018-09-20 2020-10-01 克里斯托弗 Ｓ 布萊恩特 卡貝縮宮素藥品及其製備方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH495957A (de) * 1966-09-15 1970-09-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids
US4271068A (en) * 1968-05-10 1981-06-02 Ciba-Geigy Corporation Process for the manufacture of cystine-containing peptides
CH517705A (de) * 1969-12-16 1972-01-15 Ciba Geigy Ag Verfahren zur Herstellung von Cystin-haltigen Peptiden
US3929758A (en) * 1974-09-12 1975-12-30 Armour Pharma Cyclization of cysteine-containing peptides
US4033940A (en) * 1975-11-12 1977-07-05 Armour Pharmaceutical Company Cyclization of peptides
US4093610A (en) * 1977-01-31 1978-06-06 American Home Products Corporation Process for producing triglycyl-lysine vasopressin and intermediates therefor
US4216141A (en) * 1978-07-19 1980-08-05 The Salk Institute For Biological Studies Method for cyclization of peptides
DE2923787A1 (de) * 1979-06-12 1980-12-18 Max Planck Gesellschaft Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel
IE56021B1 (en) * 1982-10-13 1991-03-27 Akzo Nv Peptides
IL77186A0 (en) * 1985-11-29 1986-04-29 Touitou Elka Pharmaceutical insulin composition
US5066716A (en) * 1988-12-13 1991-11-19 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Synthesis of chloroacetyl and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides
SE9300937L (sv) * 1993-03-19 1994-09-20 Anne Fjellestad Paulsen Komposition för oral administrering av peptider
US5500413A (en) * 1993-06-29 1996-03-19 Ferring Ab Process for manufacture of 1-deamino-8-D-arginine vasopressin
NZ268442A (en) * 1993-06-29 1996-09-25 Ferring Bv Aqueous composition of desmopressin for nasal spray administration
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions

Also Published As

Publication number Publication date
AU2151795A (en) 1995-10-09
CZ285810B6 (cs) 1999-11-17
NO963884D0 (no) 1996-09-17
BR9506989A (pt) 1997-09-16
EP0752877A1 (en) 1997-01-15
DE69517801T2 (de) 2001-02-22
JP3249970B2 (ja) 2002-01-28
CA2183862C (en) 2001-10-23
WO1995025534A1 (en) 1995-09-28
US5763405A (en) 1998-06-09
JPH10503467A (ja) 1998-03-31
ATE194290T1 (de) 2000-07-15
NZ283462A (en) 1997-03-24
DE69517801D1 (de) 2000-08-10
HUT74878A (en) 1997-02-28
PT752877E (pt) 2000-12-29
HU214826B (hu) 1998-06-29
PL316412A1 (en) 1997-01-06
FI114688B (fi) 2004-12-15
SK118596A3 (en) 1997-04-09
RO115123B1 (ro) 1999-11-30
CN1143911A (zh) 1997-02-26
AU679852B2 (en) 1997-07-10
SE9400918L (sv) 1995-09-19
FI963679A (fi) 1996-09-17
EP0752877B1 (en) 2000-07-05
RU2140790C1 (ru) 1999-11-10
NO963884L (no) 1996-09-17
PL181866B1 (pl) 2001-09-28
CA2183862A1 (en) 1995-09-28
NO316055B1 (no) 2003-12-08
CZ267696A3 (en) 1997-05-14
SK281640B6 (sk) 2001-06-11
SE9400918D0 (sv) 1994-03-18
HU9602544D0 (en) 1996-11-28
DK0752877T3 (da) 2000-10-16
FI963679A0 (fi) 1996-09-17
GR3034440T3 (en) 2000-12-29

Similar Documents

Publication Publication Date Title
ES2149979T3 (es) Composicion estabilizada para la administracion oral de peptidos.
ES2135570T3 (es) Composicion para la administracion oral de peptidos.
EP0225189A3 (en) Targeted enteral delivery system
EA200200126A1 (ru) Гидродинамически сбалансированная пероральная система доставки лекарства
ES2006649A6 (es) Una composicion para depositarse sobre la superficie de un granulo de un producto farmaceutico y procedimiento para la obtencion de la misma.
ZA200301007B (en) Process for preparing pharmaceutical compositions for use with soft gelatin formulations.
KR850700212A (ko) 서방성 약제학적 캼셀제
SE8306367L (sv) Antidiuretiskt verkande farmaceutiskt preparat
RU2449796C9 (ru) Фармацевтическая комбинация этинилэстрадиола и дроспиренона для использования в качестве контрацептива
MX9709838A (es) Composiciones farmaceuticas estables que contienen hidratos de tiludronato y proceso para producir las composiciones farmaceuticas.
EA013429B1 (ru) Препараты для перорального применения с непрерывным (постоянным) высвобождением при приеме фармацевтически активного ингредиента (api) вместе с пищей
MX9802026A (es) Formulaciones farmaceuticas que contienen darifenacina.
IL41524A (en) Pharmaceutical preparations containing the product of proline
NO964775L (no) Fast farmasöytisk adenosinholdig preparat
IT1265224B1 (it) Composizioni farmaceutiche per uso orale per il trattamento delle manifestazioni ulcerose gastro-duodenali ed esofagee
MY133368A (en) Process for preparing pharmaceutical compositions for use with soft gelatin formulations

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 752877

Country of ref document: ES